Literature DB >> 29777345

Placenta accreta and balloon catheterization: the experience of a single center and an update of latest evidence of literature.

Ferdinando Antonio Gulino1,2, F Di Guardo3, E Zambrotta3, L M Di Gregorio3, Andrea Miranda4, Stella Capriglione4, M A Palumbo3,5.   

Abstract

PURPOSE: We studied the efficacy of using pre-cesarean delivery (CD) temporary occlusion of internal iliac arteries with balloon catheters in case of placenta previa-accreta in terms of maternal and neonatal outcomes and to test accuracy of ultrasound (US) and magnetic resonance imaging (MRI) for prenatal diagnosis.
METHODS: From March 2014 to January 2018, women with an US and/or MRI diagnosis of placenta previa-accreta and a planned delivery were enrolled and divided into two groups: balloon catheterization group (women treated with preoperative catheters and CD) and control group (women candidates to elective CD).
RESULTS: 37 patients were enrolled: 16 in balloon catheterization group and 21 in control group. Significant differences were detected in estimated blood loss. Prophylactic balloon catheterization could reduce intraoperative red blood cell transfusion. The incidence of hysterectomy was lower in balloon group. No statistical difference was found for neonatal outcomes. Both US and MRI have showed to be useful and complementary to diagnose placenta previa-accreta.
CONCLUSIONS: Temporal, perioperative, and prophylactic positioning of balloon vascular catheters is an effective method for managing severe hemorrhage caused by placenta previa-accreta as it reduced intraoperative blood loss, lessened perioperative hemostatic measures and intraoperative red cell transfusions, and reduced hysterectomies.

Entities:  

Keywords:  Balloon catheterization; Blood loss; Cesarean delivery; Hysterectomy; Placenta accreta

Mesh:

Year:  2018        PMID: 29777345     DOI: 10.1007/s00404-018-4780-y

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  5 in total

Review 1.  Potential Serum Biomarkers in Prenatal Diagnosis of Placenta Accreta Spectrum.

Authors:  Tianyue Zhang; Shaowei Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-30

2.  Combined Efficacy of Balloon Occlusion and Uterine Artery Embolization on Coagulation Function in Patients with High-Risk Placenta Previa during Cesarean Section.

Authors:  Xiaoli Xu; Xiayun Zhu
Journal:  Int J Clin Pract       Date:  2022-04-04       Impact factor: 3.149

3.  The clinical evaluation of IIA balloon occlusion in caesarean delivery for patients with PAS: a retrospective study.

Authors:  Ling Hong; Aner Chen; Jinliang Chen; Xiuxiu Li; Wenming Zhuang; Yijing Shen; Qiaohong Dai; Li Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2022-02-05       Impact factor: 3.007

4.  Comparison of Placenta Previa and Placenta Accreta Spectrum Disorder Following Previous Cesarean Section between Women with a Short and Normal Interpregnancy Interval.

Authors:  Uchenna Anthony Umeh; George Uchenna Eleje; Justus Uchenna Onuh; Ogochukwu Theophilus Nwankwo; Ijeoma Victoria Ezeome; Leonard Ogbonna Ajah; Ngozi Regina Dim; Samuel Nnamdi Obi; Chidebe Christian Anikwe; Joseph Ifeanyichukwu Ikechebelu
Journal:  Obstet Gynecol Int       Date:  2022-08-03

5.  The application of prophylactic balloon occlusion of the internal iliac artery for the treatment of placenta accreta spectrum with placenta previa: a retrospective case-control study.

Authors:  Ying Peng; Lai Jiang; Cheng Peng; Dabao Wu; Ling Chen
Journal:  BMC Pregnancy Childbirth       Date:  2020-06-08       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.